Le patron d'Anthropic, Dario Amodei, a appelé samedi à ralentir la vitesse de développement de l'intelligence artificielle , citant la nécessité de mieux contrôler ses évolutions et ...
Le patron d'Anthropic, Dario Amodei, a appelé samedi à ralentir la vitesse de développement de l'intelligence artificielle , un message auquel se sont rapidement rallié Elon Musk et Sam ...
Forecasts of explosive AI progress predict that what researchers call recursive self-improvement is on the horizon. But a ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...
Сентябрьский Patch Tuesday превратился в настоящий патч-марафон: Microsoft выпустила заплатки сразу для 966 уязвимостей. Это ...
OpenAI said Wednesday it is pushing for mandatory national AI safety requirements, adding that until the U.S. Congress acts, the ChatGPT maker will continue supporting state AI legislation.
Anthropic CEO Dario Amodei called for a slowdown in frontier AI capability development in a September essay, warning that ...
On2, Anthropic CEO Dario Amodei published an essay urging AI companies to slow improvements in frontier-model capabilities ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results